{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:43:44Z","timestamp":1694652224279},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,10,21]],"date-time":"2012-10-21T00:00:00Z","timestamp":1350777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00292-012-1648-y","type":"journal-article","created":{"date-parts":[[2012,10,19]],"date-time":"2012-10-19T11:14:12Z","timestamp":1350645252000},"page":"490-495","source":"Crossref","is-referenced-by-count":1,"title":["Knochenmarkhistologie aus klinischer Sicht"],"prefix":"10.1007","volume":"33","author":[{"given":"T.","family":"Seiler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dreyling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,21]]},"reference":[{"key":"1648_CR1","unstructured":"Foucar K (2001) Bone marrow pathology, 2nd edn. American Society Clinical Pathology"},{"key":"1648_CR2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/jcp.43.8.630","volume":"43","author":"Juneja","year":"1990","unstructured":"Juneja SK, Wolf MM, Cooper IA (1990) Value of bilateral bone marrow biopsy specimens in non-Hodgkin\u2019s lymphoma. J Clin Pathol 43:630\u2013632","journal-title":"J Clin Pathol"},{"key":"1648_CR3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"Vardiman","year":"2009","unstructured":"Vardiman JW, Thiele J, Arber DA et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114:937\u2013951","journal-title":"Blood"},{"key":"1648_CR4","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.2011.36.1824","volume":"30","author":"Jerez","year":"2012","unstructured":"Jerez A, Gondek LP, Jankowska AM et al (2012) Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited. J Clin Oncol 30:1343\u20131349","journal-title":"J Clin Oncol"},{"key":"1648_CR5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2141.2005.05611.x","volume":"130","author":"Jones","year":"2005","unstructured":"Jones LK, Saha V (2005) Philadelphia positive acute lymphoblastic leukaemia of childhood. Br J Haematol 130:489\u2013500","journal-title":"Br J Haematol"},{"key":"1648_CR6","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","volume":"111","author":"Hallek","year":"2008","unstructured":"Hallek M, Cheson BD, Catovsky D et al (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 111:5446\u20135456","journal-title":"Blood"},{"key":"1648_CR7","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"D\u00f6hner","year":"2000","unstructured":"D\u00f6hner H, Stilgenbauer S, Benner A et al (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343:1910\u20131916","journal-title":"N Engl J Med"},{"key":"1648_CR8","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1056\/NEJM200208083470619","volume":"347","author":"Stilgenbauer","year":"2002","unstructured":"Stilgenbauer S, D\u00f6hner H (2002) Campath-1H-induced complete remission of chronic lymphocytic leukemia despite p53 gene mutation and resistance to chemotherapy. N Engl J Med 347(6):452\u2013453","journal-title":"N Engl J Med"},{"key":"1648_CR9","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"Damle","year":"1999","unstructured":"Damle RN, Wasil T, Fais F et al (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94:1840\u20131847","journal-title":"Blood"},{"key":"1648_CR10","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"Hamblin","year":"1999","unstructured":"Hamblin TJ, Davis Z, Gardiner A et al (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94:1848\u20131854","journal-title":"Blood"},{"key":"1648_CR11","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1182\/blood.V100.4.1410.h81602001410_1410_1416","volume":"100","author":"Krober","year":"2002","unstructured":"Krober A, Seiler T, Benner A et al (2002) V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 100:1410\u20131416","journal-title":"Blood"},{"key":"1648_CR12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579\u2013586","journal-title":"J Clin Oncol"},{"key":"1648_CR13","unstructured":"Swerdlow SS (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer"},{"key":"1648_CR14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/315550a0","volume":"315","author":"Shtivelman","year":"1985","unstructured":"Shtivelman E, Lifshitz B, Gale RP, Canaani E (1985) Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315:550\u2013554","journal-title":"Nature"},{"key":"1648_CR15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa065202","volume":"356","author":"Scott","year":"2007","unstructured":"Scott LM, Tong W, Levine RL et al (2007) JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med 356:459\u2013468","journal-title":"N Engl J Med"},{"key":"1648_CR16","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/leu.2008.233","volume":"22","author":"Kralovics","year":"2008","unstructured":"Kralovics R (2008) Genetic complexity of myeloproliferative neoplasms. Leukemia 22:1841\u20131848","journal-title":"Leukemia"},{"key":"1648_CR17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/10428190801895360","volume":"49","author":"Tefferi","year":"2008","unstructured":"Tefferi A (2008) JAK and MPL mutations in myeloid malignancies. Leuk Lymphoma 49:388\u2013397","journal-title":"Leuk Lymphoma"},{"key":"1648_CR18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2141.2009.07807.x","volume":"147","author":"Bird","year":"2009","unstructured":"Bird J, Behrens J, Westin J et al (2009) UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS). Br J Haematol 147:22\u201342","journal-title":"Br J Haematol"},{"key":"1648_CR19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ki.1993.318","volume":"44","author":"Sungur","year":"1993","unstructured":"Sungur C, Sungur A, Ruacan S et al (1993) Diagnostic value of bone marrow biopsy in patients with renal disease secondary to familial Mediterranean fever. Kidney Int 44:834\u2013836","journal-title":"Kidney Int"},{"key":"1648_CR20","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1182\/blood.V87.10.4068.bloodjournal87104068","volume":"87","author":"Emmons","year":"1996","unstructured":"Emmons RV, Reid DM, Cohen RL et al (1996) Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 87:4068\u20134071","journal-title":"Blood"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-012-1648-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-012-1648-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-012-1648-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T23:39:18Z","timestamp":1594769958000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-012-1648-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,21]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["1648"],"URL":"https:\/\/doi.org\/10.1007\/s00292-012-1648-y","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,21]]}}}